BELSAR Trademark

Trademark Overview

On Friday, October 24, 2025, a trademark application was filed for BELSAR with the United States Patent and Trademark Office. The USPTO has given the BELSAR trademark a serial number of 99460461. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, March 16, 2026. This trademark is owned by Aura Biosciences, Inc.. The BELSAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of ocular cancer and other cancers
belsar

General Information

Serial Number99460461
Word MarkBELSAR
Filing DateFriday, October 24, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, March 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2026

Trademark Statements

Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals for the treatment of ocular cancer and other cancers

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAura Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135
US

Trademark Events

Event DateEvent Description
Friday, October 24, 2025NEW APPLICATION ENTERED
Friday, October 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 24, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, March 10, 2026ASSIGNED TO EXAMINER
Tuesday, March 10, 2026NON-FINAL ACTION WRITTEN
Tuesday, March 10, 2026NON-FINAL ACTION E-MAILED
Tuesday, March 10, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2026EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 11, 2026EXAMINERS AMENDMENT E-MAILED
Wednesday, March 11, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 11, 2026EXAMINER'S AMENDMENT ENTERED
Wednesday, March 11, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

belsar cancer other cancers ocular treatment preparations therapeutic pharmaceuticals pharmaceutical